Previous Page  17 / 22 Next Page
Information
Show Menu
Previous Page 17 / 22 Next Page
Page Background

Notes:

Page 53

Analytica 2016

September 28-30, 2016

Volume 7, Issue 5(Suppl)

J Anal Bioanal Tech 2016

ISSN: 2155-9872 JABT, an open access journal

conferenceseries

.com

September 28-30, 2016 Orlando, USA

7

th

International Conference and Exhibition on

Analytical & Bioanalytical Techniques

Satoru Michiyuki et al., J Anal Bioanal Tech 2016, 7:5(Suppl)

http://dx.doi.org/10.4172/2155-9872.C1.024

The development of semi-quantitative loop-mediated isothermal amplification (LAMP) assay using

multi-well chip

Satoru Michiyuki, Takaaki Ueda

and

Yasuyoshi Mori

Eiken Chemical Co., Japan

N

ucleic acid amplification tests (NAATs) have become common tools for detecting pathogens in clinical samples. Among

NAATs, loop-mediated isothermal amplification (LAMP) assay, which enables DNA amplification and detection at

constant temperature, has the advantages of reaction simplicity, amplification efficiency and also inexpensiveness compared to

PCR-based technologies. Quantitative analysis in NAATs have been performed by kinetic analysis of amplification reactions

as in so-called “real-time PCR method” and this approach has found to be applicable to LAMP assay as well. However, these

assays require sophisticated instruments and well-trained laboratory staffs to obtain accurate and reproducible results. This

limitation has been a main obstacle to expand this type of quantitative LAMP assay to point of care tests in resource limiting

facilities. In this study, we developed simple and rapid semi-quantitative LAMP assay based on multi-well dispensing method

(multi-well qLAMP). In the presentation, we will demonstrate that our novel technology is sufficient to distinguish some

criterion of DNA levels with high reproducibility and highly correlative to conventional quantitative LAMP assay. We expect

that this technology can be applicable as point of care tests to help determination of treatment eligibility, especially in infectious

diseases whose amount of pathogenic DNA is a crucial criterion of defining treatment strategy.

Biography

Satoru Michiyuki has completed his Master’s degree from Kyushu University. He has worked as a Researcher focusing on the development of genetic clinical

diagnosis in Eiken Chemical Co., since 2011.

Satoru_Michiyuki@eiken.co.jp